Abstract
Oral fibrosarcoma (FSA) is a common oral tumour in dogs, and historically reported survival times after surgical excision range from 7.0 to 12.2 months with local recurrence rates of 32-57%. The purpose of this retrospective study was to report outcome in a cohort of dogs with oral FSA treated with surgical excision with or without adjuvant radiation therapy. Twenty-nine dogs with a histological diagnosis of FSA arising from the oral cavity that underwent surgical resection of their oral FSA were included in this study. Twenty-one dogs were treated with surgical excision alone and eight dogs with both surgery and radiation therapy. The median progression-free interval was >653 days. The median survival time was 743 days. The 1- and 2-year survival rates were 87.7 and 57.8%, respectively. Seven (24.1%) dogs developed local recurrence. Seven dogs (24.1%) developed metastasis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 33-43 |
| Number of pages | 11 |
| Journal | Veterinary and Comparative Oncology |
| Volume | 10 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2012 |
Fingerprint
Keywords
- Canine
- Fibrosarcoma
- Mandibulectomy
- Maxillectomy
- Oral tumour
ASJC Scopus subject areas
- veterinary(all)
Cite this
Outcome in dogs with surgically resected oral fibrosarcoma (1997-2008). / Frazier, S. A.; Johns, S. M.; Ortega, J.; Zwingenberger, Allison; Kent, Michael S; Hammond, G. M.; Rodriguez, C. O.; Steffey, Michele A; Skorupski, Katherine A.
In: Veterinary and Comparative Oncology, Vol. 10, No. 1, 03.2012, p. 33-43.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Outcome in dogs with surgically resected oral fibrosarcoma (1997-2008)
AU - Frazier, S. A.
AU - Johns, S. M.
AU - Ortega, J.
AU - Zwingenberger, Allison
AU - Kent, Michael S
AU - Hammond, G. M.
AU - Rodriguez, C. O.
AU - Steffey, Michele A
AU - Skorupski, Katherine A
PY - 2012/3
Y1 - 2012/3
N2 - Oral fibrosarcoma (FSA) is a common oral tumour in dogs, and historically reported survival times after surgical excision range from 7.0 to 12.2 months with local recurrence rates of 32-57%. The purpose of this retrospective study was to report outcome in a cohort of dogs with oral FSA treated with surgical excision with or without adjuvant radiation therapy. Twenty-nine dogs with a histological diagnosis of FSA arising from the oral cavity that underwent surgical resection of their oral FSA were included in this study. Twenty-one dogs were treated with surgical excision alone and eight dogs with both surgery and radiation therapy. The median progression-free interval was >653 days. The median survival time was 743 days. The 1- and 2-year survival rates were 87.7 and 57.8%, respectively. Seven (24.1%) dogs developed local recurrence. Seven dogs (24.1%) developed metastasis.
AB - Oral fibrosarcoma (FSA) is a common oral tumour in dogs, and historically reported survival times after surgical excision range from 7.0 to 12.2 months with local recurrence rates of 32-57%. The purpose of this retrospective study was to report outcome in a cohort of dogs with oral FSA treated with surgical excision with or without adjuvant radiation therapy. Twenty-nine dogs with a histological diagnosis of FSA arising from the oral cavity that underwent surgical resection of their oral FSA were included in this study. Twenty-one dogs were treated with surgical excision alone and eight dogs with both surgery and radiation therapy. The median progression-free interval was >653 days. The median survival time was 743 days. The 1- and 2-year survival rates were 87.7 and 57.8%, respectively. Seven (24.1%) dogs developed local recurrence. Seven dogs (24.1%) developed metastasis.
KW - Canine
KW - Fibrosarcoma
KW - Mandibulectomy
KW - Maxillectomy
KW - Oral tumour
UR - http://www.scopus.com/inward/record.url?scp=84857032191&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857032191&partnerID=8YFLogxK
U2 - 10.1111/j.1476-5829.2011.00272.x
DO - 10.1111/j.1476-5829.2011.00272.x
M3 - Article
C2 - 22236095
AN - SCOPUS:84857032191
VL - 10
SP - 33
EP - 43
JO - Veterinary and Comparative Oncology
JF - Veterinary and Comparative Oncology
SN - 1476-5829
IS - 1
ER -